Southwest Securities Co.Ltd(600369) : Pharmaceutical valuation is low, and it is expected to usher in a good opportunity for configuration in the future

According to the online news of the securities times, Southwest Securities Co.Ltd(600369) believes that the valuation of the pharmaceutical sector is underestimated + the performance in 2021 is still strong. Recently, the pharmaceutical sector has ushered in the best layout time point. Combined with the two main lines of the annual strategy in 2022: “through medical insurance” and “epidemic desensitization”, it is suggested that investors focus on several sector layout opportunities: Traditional Chinese medicine consumer goods / innovative drugs / undervalued value and low expectation, Varieties with upward business trend / supply chain independent and controllable related targets.